Clinical Outcome Comparison between CT-Guided Versus all MRI-Guided Scenarios in Brachytherapy for Cervical Cancer: A Single-Institute Experience.

Objectives: Image-guided adaptive brachytherapy (IGABT) is the standard of care for patients with cervical cancer. The objective of this study was to compare the treatment outcomes and adverse effects of computed tomography (CT)-guided and magnetic resonance imaging (MRI)-guided scenarios.

Materials And Methods: Data of patients with cervical cancer treated using external beam radiotherapy followed by IGABT from 2012 to 2016 were retrospectively reviewed.

Treatment of Brain Tumors in Thailand from 2005 to 2014: Data from the National Health Security Office.

Objective: To evaluate the treatment of brain tumor in Thailand. Conclusion: The treatment of brain tumors in Thailand is developed throughout the country, with better outcomes, shorter lengths of stay. The health region 1, 7, 12 and 13 have a very high ability to treat brain tumors in their areas.

Long term outcomes of patients with endometrial carcinoma treated with radiation - Siriraj Hospital experience.

Background: To evaluate treatment outcomes of patients with stage I-III endometrial cancer treated with postoperative radiation.

Materials And Methods: A retrospective review of 166 endometrial cancer patients, undergoing surgery and postoperative radiotherapy at Siriraj Hospital from 2005-2008 was performed. Pathology was reviewed.

A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancer.

Objective: Although anthracycline-based regimen is standard neoadjuvant chemotherapy (NAC) for locally advanced breast cancer (LABC), there is some concern over its toxicities such as alopecia and cardiotoxicity. Gemcitabine is another active agent in metastatic breast cancer after failure to anthracycline with less toxicity. The objective of the present study is to evaluate the efficacy and safety of the combination of gemcitabine and carboplatin as NAC in LABC.

Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day.

Objective: Evaluate the efficacy and the tolerability of preoperative chemoradiation with high dose Capecitabine.

Material And Method: Fifteen patients with locally advanced resectable rectal cancer were treated with Capecitabine 2,000 mg/m2/day, orally 7 days/week concurrent with whole pelvic irradiation 45 Gy in 25 fractions/5 weeks. Patients underwent surgery in the following 4-6 weeks.